A detailed history of Fulcrum Capital LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Fulcrum Capital LLC holds 117,905 shares of EW stock, worth $8.95 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares
117,905
Previous 113,838 3.57%
Holding current value
$8.95 Million
Previous $10.5 Million 26.01%
% of portfolio
1.72%
Previous 2.43%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$59.7 - $93.78 $242,799 - $381,403
4,067 Added 3.57%
117,905 $7.78 Million
Q2 2024

Jul 22, 2024

BUY
$84.3 - $94.31 $22,508 - $25,180
267 Added 0.24%
113,838 $10.5 Million
Q1 2024

Apr 17, 2024

BUY
$72.54 - $95.56 $34,746 - $45,773
479 Added 0.42%
113,571 $10.9 Million
Q4 2023

Jan 10, 2024

BUY
$61.71 - $77.76 $1.18 Million - $1.48 Million
19,096 Added 20.32%
113,092 $8.62 Million
Q3 2023

Oct 13, 2023

BUY
$69.28 - $93.38 $22,308 - $30,068
322 Added 0.34%
93,996 $6.51 Million
Q2 2023

Jul 27, 2023

SELL
$81.41 - $94.33 $249,847 - $289,498
-3,069 Reduced 3.17%
93,674 $8.84 Million
Q1 2023

May 10, 2023

BUY
$74.26 - $84.51 $522,344 - $594,443
7,034 Added 7.84%
96,743 $8 Million
Q4 2022

Jan 24, 2023

BUY
$68.3 - $87.44 $439,783 - $563,026
6,439 Added 7.73%
89,709 $0
Q3 2022

Oct 17, 2022

SELL
$82.37 - $107.29 $204,854 - $266,830
-2,487 Reduced 2.9%
83,270 $6.88 Million
Q2 2022

Aug 03, 2022

SELL
$86.5 - $128.27 $104,838 - $155,463
-1,212 Reduced 1.39%
85,757 $8.16 Million
Q1 2022

May 05, 2022

BUY
$101.96 - $128.34 $78,917 - $99,335
774 Added 0.9%
86,969 $10.2 Million
Q4 2021

Jan 25, 2022

BUY
$106.37 - $130.68 $110,518 - $135,776
1,039 Added 1.22%
86,195 $11.2 Million
Q3 2021

Oct 21, 2021

BUY
$102.91 - $122.75 $10,908 - $13,011
106 Added 0.12%
85,156 $9.64 Million
Q2 2021

Jul 30, 2021

BUY
$83.84 - $104.76 $192,832 - $240,948
2,300 Added 2.78%
85,050 $8.81 Million
Q1 2021

Apr 12, 2021

BUY
$78.68 - $90.67 $271,760 - $313,174
3,454 Added 4.36%
82,750 $6.92 Million
Q4 2020

Feb 09, 2021

BUY
$71.69 - $91.23 $268,765 - $342,021
3,749 Added 4.96%
79,296 $7.23 Million
Q3 2020

Oct 21, 2020

SELL
$67.19 - $87.44 $455,279 - $592,493
-6,776 Reduced 8.23%
75,547 $6.03 Million
Q2 2020

Jul 27, 2020

BUY
$57.54 - $76.95 $3.07 Million - $4.11 Million
53,395 Added 184.58%
82,323 $5.69 Million
Q1 2020

May 01, 2020

BUY
$52.41 - $81.0 $5,765 - $8,910
110 Added 0.38%
28,928 $5.46 Million
Q4 2019

Feb 03, 2020

BUY
$71.7 - $82.09 $5,305 - $6,074
74 Added 0.26%
28,818 $6.72 Million
Q3 2019

Oct 31, 2019

SELL
$61.55 - $75.43 $1,661 - $2,036
-27 Reduced 0.09%
28,744 $7.69 Million
Q2 2019

Jul 29, 2019

BUY
$55.74 - $64.41 $349,043 - $403,335
6,262 Added 27.82%
28,771 $5.32 Million
Q1 2019

May 08, 2019

BUY
$47.89 - $64.05 $31,846 - $42,593
665 Added 3.04%
22,509 $4.31 Million
Q4 2018

Feb 12, 2019

BUY
$46.41 - $56.94 $60,797 - $74,591
1,310 Added 6.38%
21,844 $3.35 Million
Q3 2018

Nov 06, 2018

BUY
$45.7 - $58.03 $21,753 - $27,622
476 Added 2.37%
20,534 $3.58 Million
Q2 2018

Aug 03, 2018

BUY
$42.45 - $51.3 $851,462 - $1.03 Million
20,058 New
20,058 $2.92 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Fulcrum Capital LLC Portfolio

Follow Fulcrum Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Capital LLC with notifications on news.